Synthesis and anticholinesterase activity and cytotoxicity of novel amide derivatives

Archiv der Pharmazie

Volumn 345, Issue 2, 2012, Pages 112-116

  Altintop, Mehlika Dilek ^a   Kaplancikli, Zafer Asim ^a   Ozdemir, Ahmet ^a   Turan Zitouni, Gülhan ^a   Temel, Halide Edip ^a   Akalín, Gülşen ^a  

^a ANADOLU UNIVERSITY   (Turkey)

Author keywords

Amide; Anticholinesterase activity; Cytotoxicity; Thiadiazole

Indexed keywords

2 (5 AMINO 1,3,4 THIADIAZOL 2 YL)THIO N (BENZOTHIAZOL 2 YL)ACETAMIDE DERIVATIVE; 2 (5 METHYL 1,3,4 THIADIAZOL 2 YL)THIO N (BENZOTHIAZOL 2 YL)ACETAMIDE DERIVATIVE; 2 CHLORO N (BENZOTHIAZOL 2 YL)ACETAMIDE DERIVATIVE; AMIDE; CHOLINESTERASE INHIBITOR; N (BENZOTHIAZOL 2 YL) 2 [(5 AMINOMETHYL 1,3,4 THIADIAZOL 2 YL)THIO]ACETAMIDE DERIVATIVE; THIOACETAMIDE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; CHEMICAL STRUCTURE; CYTOTOXICITY; ENZYME ACTIVITY; MASS SPECTROMETRY; NONHUMAN; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SPECTROPHOTOMETRY; SYNTHESIS;

AMIDES; ANIMALS; CELL SURVIVAL; CHOLINESTERASE INHIBITORS; MICE; NIH 3T3 CELLS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84856324282     PISSN: 03656233     EISSN: 15214184     Source Type: Journal    
DOI: 10.1002/ardp.201100124     Document Type: Article

References (22)

1. A. Martinez, A. Castro, Expert Opin. Investig. Drugs 2006, 15, 1-12.
2. E. Giacobini, Neurochem. Res. 2003, 28, 515-522.
3. Z.-X. Shen, Med. Hypotheses 2004, 63, 298-307.
4. J. Grutzendler, J. C. Morris, Drugs 2001, 61, 41-52.
5. G. Pepeu, M. G. Giovannini, Curr. Alzheimer Res. 2009, 6, 86-96.
6. J. B. Standridge, Clin. Ther. 2004, 26, 615-630.
7. P. Johannsen, CNS Drugs 2004, 18, 757-768.
8. G. T. Grossberg, Curr. Ther. Res. Clin. Exp. 2003, 64, 216-235.
9. D. G. Wilkinson, P. T. Francis, E. Schwam, J. Payne-Parrish, Drugs Aging 2004, 21, 453-478.
10. T. L. Lemke, D. A. Williams, in: Foye's Principles of Medicinal Chemistry, Lippincott Williams&Wilkins, Baltimore and Philadelphia, USA 2008, chapter 12.
11. G. A. Patani, E. J. LaVoie, Chem. Rev. 1996, 96, 3147-3176.
12. P. Ciapetti, B. Giethlen, in Molecular Variations Based on Isosteric Replacements. in, C. M. Wermuth, The Practice of Medicinal Chemistry, Academic Press Burlington, USA 2008, p. 290-342.
13. S. Darvesh, R. S. McDonald, A. Penwell, S. Conrad, K. V. Darvesh, D. Mataija, G. Gomez, A. Caines, R. Walsh, E. Martin, Bioorg. Med. Chem. 2005, 13, 211-222.
14. S. Darvesh, R. S. McDonald, K. V. Darvesh, D. Mataija, S. Conrad, G. Gomez, R. Walsh, E. Martin, Bioorg. Med. Chem. 2007, 15, 6367-6378.
15. A. K. Sengupta, M. Garg, J. Indian Chem. Soc. 1980, 1241-1243.
16. H. K. Misra, Arch. Pharm. 1983, 316, 487-493.
17. A. K. Sen Gupta, H. K. Misra, J. Pharm. Sci. 1980, 69, 1313-1317.
18. P. N. Bhargava, P. Ram, Bull. Chem. Soc. Japan 1965, 38, 339-341.
19. D. S. Goldfarb, US 20090163545 A1. 2009.
20. G. L. Ellman, K. D. Courtney, V. J. Anders, R. M. Featherstone, Biochem. Pharmacol. 1961, 7, 88-95.
21. T. Mossmann, J. Immunol. Methods 1983, 65, 55-63.
22. K. Keiser, C. C. Johnson, D. A. Tipton, J. Endod. 2000, 26, 288-291.